Therapeutic infusion of partially HLA-matched third-party virus-specific T cells (VST) for treatment of refractory viral infection in haematopoietic stem cell transplant (HSCT) and renal transplant patients

Withers Barbara; Blyth Emily; Clancy Leighton; Simms Renee; Burgess Jane; Ma Chun Kei Kris; Micklethwaite Ken; Gottlieb David

首页> 外文期刊>Xenotransplantation >Therapeutic infusion of partially HLA-matched third-party virus-specific T cells (VST) for treatment of refractory viral infection in haematopoietic stem cell transplant (HSCT) and renal transplant patients

【24h】

Therapeutic infusion of partially HLA-matched third-party virus-specific T cells (VST) for treatment of refractory viral infection in haematopoietic stem cell transplant (HSCT) and renal transplant patients

机译：治疗性输注部分HLA匹配的第三方病毒特异性T细胞（VST），用于治疗造血干细胞移植（HSCT）和肾移植患者的难治性病毒感染

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Xenotransplantation》 |2015年第1期|共1页
作者
Withers Barbara; Blyth Emily; Clancy Leighton; Simms Renee; Burgess Jane; Ma Chun Kei Kris; Micklethwaite Ken; Gottlieb David;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类器官移植术;
关键词

相似文献

外文文献
中文文献
专利

1. Therapeutic infusion of partially HLA-matched third-party virus-specific T cells (VST) for treatment of refractory viral infection in haematopoietic stem cell transplant (HSCT) and renal transplant patients [J] . Withers Barbara, Blyth Emily, Clancy Leighton, Xenotransplantation . 2015,第Suppla1期

机译：治疗性输注部分HLA匹配的第三方病毒特异性T细胞（VST），用于治疗造血干细胞移植（HSCT）和肾移植患者的难治性病毒感染
2. Early Experience With CliniMACS Prodigy CCS (IFN-gamma) System in Selection of Virus-specific T Cells From Third-party Donors for Pediatric Patients With Severe Viral Infections After Hematopoietic Stem Cell Transplantation [J] . Kallay Krisztian, Kassa Csaba, Reti Marienn, Journal of immunotherapy . 2018,第3期

机译：在造血干细胞移植后选择来自第三方供体的第三方供体的病毒特异性T细胞的早期经验
3. Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients [J] . Baugh Katherine A., Tzannou Ifigeneia, Leen Ann M. Current opinion in infectious diseases . 2018,第4期

机译：用于治疗造血干细胞移植患者病毒感染治疗病毒感染的细胞毒性T淋巴细胞输注
4. HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH PRIMARY SYSTEMIC AMYLOIDOSIS (AL): AN ABMTR STUDY [C] . DH Vesole, W Perez, D Reece, International Symposium on Amyloidosis . 2005

机译：具有自体造血干细胞移植（HSCT）的高剂量治疗用于初级全身淀粉样蛋白症（AL）的患者：ABMTR研究
5. Clinical and Economic Burden of Respiratory Viral Infections in Hematopoietic Stem Cell Transplant (HSCT) Recipients. [D] . Ghantoji, Shashank S. 2017

机译：造血干细胞移植（HSCT）收件人的呼吸道病毒感染的临床和经济负担。
6. Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells [O] . Barbara Withers, Emily Blyth, Leighton E. Clancy, 2017

机译：与第三方病毒特异性T细胞同种异体HSCT后的复发或难治性病毒感染的长期控制
7. Aprepitant: Treatment in Haematopoietic Stem Cell Transplantation (HSCT) Patients Refractory to First and Second Line Antiemetics [O] . Booth D. 2011

机译：Aprepitant：一线和二线止吐药难以治疗的造血干细胞移植（HSCT）患者的治疗

Therapeutic infusion of partially HLA-matched third-party virus-specific T cells (VST) for treatment of refractory viral infection in haematopoietic stem cell transplant (HSCT) and renal transplant patients

著录项

相似文献

相关主题

期刊订阅